Association between type III collagen degradation and local tissue damage of a single joint
Objective: The development of disease-modifying drugs is limited by OA's heterogeneity and the challenge of defining clinical endpoints. Serological biomarkers are considered potential surrogate endpoints, but their contribution from single joints to systemic levels in OA patients is unclear. I...
Saved in:
| Main Authors: | Christian S. Thudium, Sten Rasmussen, Morten A. Karsdal, Anne-Christine Bay-Jensen |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2024-12-01
|
| Series: | Osteoarthritis and Cartilage Open |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2665913124000943 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Oral administration of hydrolyzed collagen alleviates pain and enhances functionality in knee osteoarthritis: Results from a randomized, double-blind, placebo-controlled study
by: Juan Antonio Carrillo-Norte, et al.
Published: (2025-02-01) -
Regulation of fibronectin and collagens type I, III and VI by TNF-α, TGF-β, IL-13, and tofacitinib
by: Frederik S. Gillesberg, et al.
Published: (2025-01-01) -
ASSESSMENT OF THE RESULTS OF REVISION HIP AND KNEE REPLACEMENT SURGERY IN CASE OF PERIPROSTHETIC INFECTION
by: Alexey L. Kameka, et al.
Published: (2024-03-01) -
Applications of type I and II collagen in osteochondral tissue engineering: Respective features and future perspectives
by: Ruoyu Huang, et al.
Published: (2024-12-01) -
Impact of High Glucose on Bone Collagenous Matrix Composition, Structure, and Organization: An Integrative Analysis Using an Ex Vivo Model
by: Rita Araújo, et al.
Published: (2025-01-01)